Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed

INTRODUCTION: The objective was to use the evidence-based medicine metrics of number needed to treat, number needed to harm, and likelihood to be helped or harmed to appraise the clinical efficacy and tolerability of sublingual dexmedetomidine in adults with agitation associated with schizophrenia o...

Descripción completa

Detalles Bibliográficos
Autores principales: Citrome, Leslie, Risinger, Robert, Rajachandran, Lavanya, Robison, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464744/
https://www.ncbi.nlm.nih.gov/pubmed/36002761
http://dx.doi.org/10.1007/s12325-022-02274-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464744/
https://www.ncbi.nlm.nih.gov/pubmed/36002761
http://dx.doi.org/10.1007/s12325-022-02274-3

Ejemplares similares